425: Bellevue Life Sciences Acquisition Corp. Urges Stockholders to Vote for Extension Amendment

Bellevue Life Sciences Acquisition Corp. reminds stockholders to vote in favor of the proposal to extend the date by which it has to consummate a business combination at the upcoming Special Meeting on May 14, 2024.

Summary

• Bellevue Life Sciences Acquisitions Corp. (BLAC) is urging its stockholders to vote in favor of an extension amendment at the Special Meeting reconvening on May 14, 2024.
• The extension would allow BLAC more time to complete its business combination with OSR Holdings Co., Ltd., a South Korean healthcare holding company.
• The proposal seeks to extend the deadline for completing the business combination from May 14, 2024, to November 14, 2024.
• Stockholders are not being asked to vote on the proposed business combination itself at this time.
• If the extension is not approved by at least 65% of outstanding shares, BLAC will commence liquidation.
• Stockholders who previously requested redemption of their shares can withdraw their tender prior to the vote on May 14, 2024.
• BLAC has engaged Advantage Proxy to assist stockholders with voting and answer any questions.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document is primarily a reminder and request for stockholders to vote on a previously announced extension. While the company emphasizes the importance of the extension, it also acknowledges the risk of liquidation if the extension is not approved.

Positives

• The extension provides BLAC with additional time to finalize its business combination with OSR Holdings.
• Stockholders retain the option to withdraw previously submitted redemption requests.
• BLAC has engaged a proxy solicitor to assist stockholders with the voting process.

Negatives

• Failure to secure the extension will result in the liquidation of BLAC, preventing stockholders from capitalizing on the potential business combination with OSR Holdings.

Risks

• The business combination with OSR Holdings may not be completed even if the extension is approved.
• International, national and local economic conditions, merger, acquisition and business combination risks, financing risks, geo-political risks, acts of terror or war could impact the business combination.
• The document references risk factors described in BLAC's Annual Report on Form 10-K filed with the SEC on April 17, 2024, and in the prospectus dated February 9, 2023.

Future Outlook

The future outlook depends on the approval of the extension amendment and the successful completion of the business combination with OSR Holdings.

Management Comments

• BLAC encourages stockholders to vote in favor of the proposal to extend the date by which BLAC has to consummate a business combination.
• Every stockholders vote is important, regardless of the number of shares the stockholder holds.
• BLAC strongly recommends that stockholders submit their proxies electronically or by telephone by 11:59p.m. ET on May 13, 2024.

Industry Context

SPACs often seek extensions to complete their business combinations, especially in volatile market conditions or when facing regulatory hurdles. The success of this extension vote is critical for BLAC to remain viable and pursue its merger with OSR Holdings.

Comparison to Industry Standards

• SPACs typically require a majority vote, often two-thirds, to approve extensions, aligning with BLAC's 65% threshold.
• The timeline for SPAC mergers varies, but a six-month extension is within the typical range sought by SPACs facing delays.
• Redemption rates in SPAC mergers have been volatile, making it crucial for BLAC to retain stockholder support and minimize redemptions.

Stakeholder Impact

• Shareholders will be impacted by the outcome of the vote, with potential for gains from the business combination or losses from liquidation.
• Employees of BLAC and OSR Holdings may be affected by the success or failure of the business combination.

Next Steps

• Stockholders to vote on the extension amendment at the Special Meeting on May 14, 2024.
• BLAC to proceed with the business combination with OSR Holdings if the extension is approved.
• BLAC to commence liquidation if the extension is not approved.

Key Dates